GLP-1 Drugs Are Reshaping Chronic Disease: Here’s What Public Health Needs to Know
Here is where we are in 2026. Obesity affects more than 1 billion people worldwide and was associated with 3.7 million deaths globally in 2024. Without decisive action, that number is projected to double by 2030. And for the first time in decades, there is a class of medications that appears capable of meaningfully shifting […]
Read more →